Ameritas Investment Partners, Inc. Fennec Pharmaceuticals Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,499 shares of FENC stock, worth $10,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,499
Previous 1,499
-0.0%
Holding current value
$10,328
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding FENC
# of Institutions
67Shares Held
14.6MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$28.1 Million0.71% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$16.6 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$15.5 Million11.1% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$8.18 Million0.0% of portfolio
-
Dg Capital Management, LLC New York, NY1.11MShares$7.68 Million2.94% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $180M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...